General Information
Version
8.2
Revision date
2022-10-11
Product name
CMV DFA KIT
REACH No
This
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H332, H311, H412
Hazard statements
Code
Statements
H302+H332
Harmful if swallowed or if inhaled
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H302 + H332 Harmful if swallowed or if inhaled. H311 Toxic in contact with skin. H412 Harmful to aquatic life with long lasting effects. H311 Toxic in contact with skin. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P280 Wear protective gloves/ protective clothing. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
- none
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 3), H311 Long-term (chronic) aquatic hazard (Category 3), H412 For the full text of the H-Statements mentioned in this Section, see Section 16.
